• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.通过微阵列研究鉴定人巨噬细胞半乳糖型凝集素的二级结合位点:对其配体分子识别的意义。
J Biol Chem. 2019 Jan 25;294(4):1300-1311. doi: 10.1074/jbc.RA118.004957. Epub 2018 Nov 30.
2
Delineating binding modes of Gal/GalNAc and structural elements of the molecular recognition of tumor-associated mucin glycopeptides by the human macrophage galactose-type lectin.描绘半乳糖/ N - 乙酰半乳糖胺的结合模式以及人巨噬细胞半乳糖型凝集素对肿瘤相关粘蛋白糖肽分子识别的结构元件。
Chemistry. 2014 Dec 1;20(49):16147-55. doi: 10.1002/chem.201404566. Epub 2014 Oct 16.
3
Crystal Structure of the Carbohydrate Recognition Domain of the Human Macrophage Galactose C-Type Lectin Bound to GalNAc and the Tumor-Associated Tn Antigen.人巨噬细胞半乳糖凝集素的碳水化合物识别域与半乳糖胺和肿瘤相关的 Tn 抗原复合物的晶体结构
Biochemistry. 2021 May 4;60(17):1327-1336. doi: 10.1021/acs.biochem.1c00009. Epub 2021 Mar 16.
4
The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.树突状细胞表达的C型凝集素MGL可检测结肠癌中MUC1上的聚糖变化。
Cancer Immunol Immunother. 2007 Aug;56(8):1225-36. doi: 10.1007/s00262-006-0274-z. Epub 2006 Dec 29.
5
Characterization of Macrophage Galactose-type Lectin (MGL) ligands in colorectal cancer cell lines.鉴定结直肠癌细胞系中巨噬细胞半乳糖型凝集素(MGL)配体。
Biochim Biophys Acta Gen Subj. 2020 Apr;1864(4):129513. doi: 10.1016/j.bbagen.2020.129513. Epub 2020 Jan 3.
6
Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.糖肽作为树突状细胞的靶点:探索 MUC1 糖肽与巨噬细胞半乳糖型凝集素 (MGL) 同源物的结合谱。
J Med Chem. 2017 Nov 9;60(21):9012-9021. doi: 10.1021/acs.jmedchem.7b01242. Epub 2017 Oct 31.
7
Synthesis and Thermodynamic Evaluation of Sialyl-Tn MUC1 Glycopeptides Binding to Macrophage Galactose-Type Lectin.唾液酸化-Tn MUC1 糖肽与巨噬细胞半乳糖型凝集素的结合的合成与热力学评价。
Chembiochem. 2024 Sep 16;25(18):e202400391. doi: 10.1002/cbic.202400391. Epub 2024 Jul 30.
8
Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells.肿瘤相关的Tn-MUC1糖型通过巨噬细胞半乳糖型C型凝集素内化,并被递送至树突状细胞中的HLA I类和II类区室。
Cancer Res. 2007 Sep 1;67(17):8358-67. doi: 10.1158/0008-5472.CAN-07-1035.
9
The Plasticity of the Carbohydrate Recognition Domain Dictates the Exquisite Mechanism of Binding of Human Macrophage Galactose-Type Lectin.碳水化合物识别结构域的可塑性决定了人源巨噬细胞半乳糖型凝集素精细的结合机制。
Chemistry. 2019 Nov 4;25(61):13945-13955. doi: 10.1002/chem.201902780. Epub 2019 Oct 1.
10
Calorimetric Analysis of the Interplay between Synthetic Tn Antigen-Presenting MUC1 Glycopeptides and Human Macrophage Galactose-Type Lectin.合成 Tn 抗原呈递 MUC1 糖肽与人巨噬细胞半乳糖型凝集素相互作用的量热分析。
Biochemistry. 2021 Feb 23;60(7):547-558. doi: 10.1021/acs.biochem.0c00942. Epub 2021 Feb 9.

引用本文的文献

1
Implications of Mucin-Type -Glycosylation in Alzheimer's Disease.粘蛋白型糖基化在阿尔茨海默病中的意义
Molecules. 2025 Apr 24;30(9):1895. doi: 10.3390/molecules30091895.
2
Production of GcMAF with Anti-Inflammatory Properties and Its Effect on Models of Induced Arthritis in Mice and Cystitis in Rats.具有抗炎特性的GcMAF的产生及其对小鼠诱导性关节炎模型和大鼠膀胱炎模型的影响。
Curr Issues Mol Biol. 2024 Sep 28;46(10):10934-10959. doi: 10.3390/cimb46100650.
3
Ligand Recognition by the Macrophage Galactose-Type C-Type Lectin: Self or Non-Self?-A Way to Trick the Host's Immune System.巨噬细胞半乳糖型 C 型凝集素的配体识别:自身或非自身?——一种欺骗宿主免疫系统的方法。
Int J Mol Sci. 2023 Dec 3;24(23):17078. doi: 10.3390/ijms242317078.
4
Tn antigen interactions of macrophage galactose-type lectin (MGL) in immune function and disease.巨噬细胞半乳糖型凝集素(MGL)在免疫功能和疾病中的 Tn 抗原相互作用。
Glycobiology. 2023 Dec 25;33(11):879-887. doi: 10.1093/glycob/cwad083.
5
The unique 3D arrangement of macrophage galactose lectin enables lipopolysaccharide recognition through two distinct interfaces.巨噬细胞半乳糖凝集素独特的三维结构使其能够通过两个不同的界面识别脂多糖。
PNAS Nexus. 2023 Sep 20;2(9):pgad310. doi: 10.1093/pnasnexus/pgad310. eCollection 2023 Sep.
6
MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response.MUC1 糖肽疫苗与半乳糖凝集素簇修饰物缀合,靶向树突状细胞上的巨噬细胞半乳糖型 C 型凝集素,从而引发改善的体液免疫应答。
J Am Chem Soc. 2023 Jun 21;145(24):13027-13037. doi: 10.1021/jacs.2c12843. Epub 2023 Jun 6.
7
Glycomimetics for the inhibition and modulation of lectins.糖基模拟物抑制和调节凝集素。
Chem Soc Rev. 2023 Jun 6;52(11):3663-3740. doi: 10.1039/d2cs00954d.
8
Recent Progress in Development and Application of DNA, Protein, Peptide, Glycan, Antibody, and Aptamer Microarrays.DNA、蛋白质、肽、聚糖、抗体和适体微阵列的开发和应用的最新进展。
Biomolecules. 2023 Mar 27;13(4):602. doi: 10.3390/biom13040602.
9
Glyco-binding domain chimeric antigen receptors as a new option for cancer immunotherapy.糖基结合域嵌合抗原受体作为癌症免疫治疗的新选择。
Gene Ther. 2023 Aug;30(7-8):603-611. doi: 10.1038/s41434-022-00374-x. Epub 2022 Dec 19.
10
Lung Tumor Cells with Different Tn Antigen Expression Present Distinctive Immunomodulatory Properties.不同 Tn 抗原表达的肺癌肿瘤细胞呈现出不同的免疫调节特性。
Int J Mol Sci. 2022 Oct 10;23(19):12047. doi: 10.3390/ijms231912047.

本文引用的文献

1
Water Sculpts the Distinctive Shapes and Dynamics of the Tumor-Associated Carbohydrate Tn Antigens: Implications for Their Molecular Recognition.水塑造了肿瘤相关碳水化合物 Tn 抗原的独特形状和动态:对其分子识别的影响。
J Am Chem Soc. 2018 Aug 8;140(31):9952-9960. doi: 10.1021/jacs.8b04801. Epub 2018 Jul 30.
2
The tumour glyco-code as a novel immune checkpoint for immunotherapy.肿瘤糖码作为免疫治疗的新型免疫检查点。
Nat Rev Immunol. 2018 Mar;18(3):204-211. doi: 10.1038/nri.2018.3. Epub 2018 Feb 5.
3
A novel role for the macrophage galactose-type lectin receptor in mediating von Willebrand factor clearance.巨噬细胞半乳糖凝集素受体在介导血管性血友病因子清除中的新作用。
Blood. 2018 Feb 22;131(8):911-916. doi: 10.1182/blood-2017-06-787853. Epub 2017 Dec 27.
4
Glycopeptides as Targets for Dendritic Cells: Exploring MUC1 Glycopeptides Binding Profile toward Macrophage Galactose-Type Lectin (MGL) Orthologs.糖肽作为树突状细胞的靶点:探索 MUC1 糖肽与巨噬细胞半乳糖型凝集素 (MGL) 同源物的结合谱。
J Med Chem. 2017 Nov 9;60(21):9012-9021. doi: 10.1021/acs.jmedchem.7b01242. Epub 2017 Oct 31.
5
Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides.粘蛋白结构原则:对基于 MUC1-糖肽的癌症疫苗的合理设计的启示。
Chem Soc Rev. 2017 Nov 27;46(23):7154-7175. doi: 10.1039/c6cs00858e.
6
GalNAc-Tyrosine Is a Ligand of Plant Lectins, Antibodies, and Human and Murine Macrophage Galactose-Type Lectins.N-乙酰半乳糖胺-酪氨酸是植物凝集素、抗体以及人和小鼠巨噬细胞半乳糖型凝集素的配体。
ACS Chem Biol. 2017 Aug 18;12(8):2172-2182. doi: 10.1021/acschembio.7b00471. Epub 2017 Jul 14.
7
Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.MUC1 的糖基化通过改变抗原的构象平衡来影响治疗性抗体的结合。
Glycobiology. 2017 Jul 1;27(7):677-687. doi: 10.1093/glycob/cww131.
8
A Multivalent Marine Lectin from Crenomytilus grayanus Possesses Anti-cancer Activity through Recognizing Globotriose Gb3.来自灰胡桃蛤的一种多价海洋凝集素通过识别Globotriose Gb3具有抗癌活性。
J Am Chem Soc. 2016 Apr 13;138(14):4787-95. doi: 10.1021/jacs.6b00111. Epub 2016 Apr 1.
9
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.甘露糖结合凝集素(MGL)配体表达与BRAF突变相关,并与III期结肠癌患者的不良生存率相关。
Oncotarget. 2015 Sep 22;6(28):26278-90. doi: 10.18632/oncotarget.4495.
10
Recent insights into structures and functions of C-type lectins in the immune system.免疫系统中C型凝集素的结构与功能的最新见解。
Curr Opin Struct Biol. 2015 Oct;34:26-34. doi: 10.1016/j.sbi.2015.06.003. Epub 2015 Jul 7.

通过微阵列研究鉴定人巨噬细胞半乳糖型凝集素的二级结合位点:对其配体分子识别的意义。

Identification of a secondary binding site in human macrophage galactose-type lectin by microarray studies: Implications for the molecular recognition of its ligands.

机构信息

Departamento de Química, Faculdade de Ciências e Tecnologia, UCIBIO, REQUIMTE, 2829-516 Caparica, Portugal.

Complex Carbohydrate Research Center, University of Georgia, Athens, Georgia 30602.

出版信息

J Biol Chem. 2019 Jan 25;294(4):1300-1311. doi: 10.1074/jbc.RA118.004957. Epub 2018 Nov 30.

DOI:10.1074/jbc.RA118.004957
PMID:30504228
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6349122/
Abstract

The human macrophage galactose-type lectin (MGL) is a C-type lectin characterized by a unique specificity for terminal GalNAc residues present in the tumor-associated Tn antigen (αGalNAc-Ser/Thr) and its sialylated form, the sialyl-Tn antigen. However, human MGL has multiple splice variants, and whether these variants have distinct ligand-binding properties is unknown. Here, using glycan microarrays, we compared the binding properties of the short MGL 6C (MGL) and the long MGL 6B (MGL) splice variants, as well as of a histidine-to-threonine mutant (MGL H259T). Although the MGL and MGL variants displayed similar binding properties on the glycan array, the MGL H259T mutant failed to interact with the sialyl-Tn epitope. As the MGL H259T variant could still bind a single GalNAc monosaccharide on this array, we next investigated its binding characteristics to Tn-containing glycopeptides derived from the MGL ligands mucin 1 (MUC1), MUC2, and CD45. Strikingly, in the glycopeptide microarray, the MGL H259T variant lost high-affinity binding toward Tn-containing glycopeptides, especially at low probing concentrations. Moreover, MGL H259T was unable to recognize cancer-associated Tn epitopes on tumor cell lines. Molecular dynamics simulations indicated that in WT MGL, His mediates H bonds directly or engages the Tn-glycopeptide backbone through water molecules. These bonds were lost in MGL H259T, thus explaining its lower binding affinity. Together, our results suggest that MGL not only connects to the Tn carbohydrate epitope, but also engages the underlying peptide via a secondary binding pocket within the MGL carbohydrate recognition domain containing the His residue.

摘要

人源巨噬细胞半乳糖型凝集素(MGL)是一种 C 型凝集素,其特征在于对肿瘤相关 Tn 抗原(αGalNAc-Ser/Thr)及其唾液酸化形式,即唾液酸化-Tn 抗原的末端 GalNAc 残基具有独特的特异性。然而,人源 MGL 具有多个剪接变体,这些变体是否具有不同的配体结合特性尚不清楚。在这里,我们使用聚糖微阵列比较了短型 MGL 6C(MGL)和长型 MGL 6B(MGL)剪接变体以及组氨酸到苏氨酸突变体(MGL H259T)的结合特性。尽管 MGL 和 MGL 变体在糖基阵列上显示出相似的结合特性,但 MGL H259T 突变体未能与唾液酸化-Tn 表位相互作用。由于 MGL H259T 变体仍能与该阵列上的单个 GalNAc 单糖结合,我们接下来研究了其与源自 MGL 配体粘蛋白 1(MUC1)、MUC2 和 CD45 的含有 Tn 的糖肽的结合特征。引人注目的是,在糖肽微阵列中,MGL H259T 变体对含有 Tn 的糖肽的高亲和力结合丧失,尤其是在低探测浓度下。此外,MGL H259T 无法识别肿瘤细胞系上的癌症相关 Tn 表位。分子动力学模拟表明,在 WT MGL 中,His 通过直接形成氢键或通过水分子与 Tn-糖肽主链相互作用。在 MGL H259T 中,这些键丢失了,因此解释了其较低的结合亲和力。总之,我们的结果表明,MGL 不仅与 Tn 碳水化合物表位连接,而且还通过包含 His 残基的 MGL 碳水化合物识别结构域中的次级结合口袋与潜在的肽结合。